Table 1.
Distribution of responses relating to HIV/AIDS pain (distribution of physicians’ responses for each of the possible barriers to opioid use in the management of HIV-/AIDS-related pain; n = 73).
| Not a problem | Minor problem | Moderate problem | Serious problem | Do not know | No response | |
|---|---|---|---|---|---|---|
| Prescription forms | 6 (8.21%) | 4 (5.47%) | 2 (2.73%) | 6 (8.21) | 50 (68.49%) | 5 (6.84%) |
| Program licensing | 2 (2.73%) | 2 (2.73%) | 0 | 5 (6.84%) | 58 (79.45%) | 6 (6.84%) |
| Shortage of opioids | 5 (6.84%) | 6 (8.21%) | 3 (4.10%) | 2 (2.73%) | 49 (67.12%) | 8 (10.95%) |
| Physicians | 9 (12.32%) | 0 | 8 (10.95%) | 5 (6.84%) | 44 (60.27%) | 7 (9.58%) |
| Pharmacists | 1 (1.36%) | 4 (5.47%) | 3 (4.10%) | 10 (13.68%) | 49 (67.12%) | 6 (8.21%) |
| Nurses | 5 (6.84%) | 3 (4.10%) | 3 (4.10%) | 6 (8.21%) | 50 (68.49%) | 6 (8.21%) |
| Patients | 7 (9.58%) | 4 (5.47%) | 8 (10.95%) | 1 (1.36%) | 46 (63.01%) | 7 (7.58%) |
| Costs | 8 (10.95%) | 2 (2.73%) | 7 (9.58%) | 2 (2.73%) | 48 (65.75%) | 6 (8.21%) |
| Doses | 6 (8.21%) | 8 (10.95%) | 2 (2.73%) | 4 (5.47%) | 45 (61.64%) | 8 (10.95%) |
| Regulations | 4 (5.47%) | 2 (2.73%) | 6 (8.20%) | 11 (15.06%) | 44 (60.27%) | 6 (8.21%) |
| Availability for home use | 2 (2.73%) | 6 (8.21) | 3 (4.10%) | 10 (13.69%) | 45 (61.64%) | 7 (9.58%) |
| Physician licensing | 7 (9.58%) | 3 (4.10%) | 2 (2.73%) | 3 (4.10%) | 52 (71.23%) | 6 (8.21%) |